HuiYong Zhao

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS

Zhan Yao, Rona Yaeger, Vanessa Rodrik-Outmezguine et al. · Nature · 2017 · 540 citations

Oncology, Activated Ras, Class 3 +12

EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

Vito Amodio, Rona Yaeger, Pamela Arcella et al. · Cancer Discovery · 2020 · 443 citations · Full text

Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease

Faranak Fattahi, Julius A. Steinbeck, Sonja Kriks et al. · Nature · 2016 · 298 citations · Full text

Human Cell, Cell Lineage, Cell Therapy +7

Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer

Zeda Zhang, Wouter R. Karthaus, Young Sun Lee et al. · Cancer Cell · 2020 · 240 citations · Full text

Medicine, Tumor Suppressor, Prostatic Disease +4

ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer

Guotai Xu, Sagar Chhangawala, Emiliano Cocco et al. · Nature Genetics · 2020 · 225 citations · Full text

Radiation Oncology, Breast Oncology, Medicine +10